BGLAP and type 2 diabetes mellitus: Research has also indicated that individuals with T2DM exhibit reduced bone turnover, particularly in markers of bone formation such as osteocalcin (OC) and procollagen type I N-terminal peptide (P1NP), as well as in the bone resorption marker C-terminal telopeptide of type I collagen (CTX).